IMPRINT
Pantarhei Oncology BV | Boulevard 17 | 3707 BK Zeist | The Netherlands
Phone: +31 (0)30 6 985 020 | Email: info@pantarheioncology.nl
DISCLAIMER
The information contained in this website is for general information purposes only. The information is provided by Pantarhei Oncology and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
SOCIAL MEDIA
© 2021
13th European Society of Gynecology (ESG) Congress, October 16-19, 2019, Vienna, Austria
/in News /by Astrid van den HeuvelOn Thursday October 17, 2019, Herjan Coelingh Bennink of Pantarhei Oncology lectured on: “Estetrol for the treatment of advanced breast cancer” in a symposium entitled “Breast cancer: new challenges in diagnosis, pathogenesis and therapy”. The symposium was chaired by Xiangyan Ruan and Kerstin Rhiem.
For more information, please read the abstract.
Pantarhei Oncology Change of Address
/in News /by Pantarhei Oncology BVBeginning of September, Pantarhei Oncology has moved the office to a new building. The new address is Boulevard 17, 3707 BK Zeist, the Netherlands. For more information, see change-of-address.
12th European Congress on Menopause and Andropause, May 15-17, 2019, Berlin
/in News /by Pantarhei Oncology BVOn Thursday May 16, 2019, Pantarhei Oncology sponsored a symposium entitled “Treatment of Breast Cancer and Prostate Cancer with the Fetal Estrogen Estetrol”. Lectures were presented by Herjan Coelingh Bennink (The profile of the fetal estrogen estetrol [E4]), Hans Georg Lenhard (Treatment of advanced breast cancer with E4) and Frans Debruyne (Treatment of advanced prostate cancer with E4). The session was chaired by Tomasso Simoncini and Yvette Zimmerman.